Reckitt Benckiser Group PLC — Director's Dealing 2017

Feb 28, 2017

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1173Y

Reckitt Benckiser Group PLC

28 February 2017

28 February 2017

RECKITT BENCKISER GROUP PLC

DIRECTOR/PDMR SHAREHOLDING

Reckitt Benckiser Group plc (the "Company" or "RB") announces the following changes in the interests of a Person Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").

Reckitt Benckiser Group 2015 Long Term incentive Plan (the "LTIP")

On 27 February 2017 awards over Shares were made under the LTIP to the PDMR listed below:

Name	Director / PDMR	Total Number of Share Options	Total Number of Shares under conditional award
Rupert Bondy	PDMR	67,500	38,917

The number of Shares and options shown is the maximum available if performance conditions relating to awards are satisfied in full.  There will be no retesting of these awards.  No consideration was paid for the grant of the awards. Options will be exercisable at £71.81 per share.

The following notifications are made in accordance with the requirements of the EU Market Abuse Regulation.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Rupert Bondy

2

Reason for the notification

a)

Position/status

PDMR - SVP, Group General Counsel and Company Secretary

b)

Initial notification/

Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Reckitt Benckiser Group plc

b)

LEI

5493003JFSMOJG48V108

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Share options and conditional share awards over ordinary shares of 10p each in Reckitt Benckiser Group plc

GB00B24CGK77 - ID code for ordinary shares

b)

Nature of the transaction

Grant under the Reckitt Benckiser Group 2015 Long-Term Incentive Plan of

1.   share options, and

2.   shares under conditional award

1.  22,500 share options may vest in May 2019, subject to achievement of performance conditions for the three year performance period ending on 31 December 2018 and 45,000 share options may vest in May 2020, subject to the achievement of performance conditions for the three year performance period ending on 31 December 2019.

2.  5,167 shares may vest in May 2018 subject to continued employment, 11,250 shares may vest in May 2019, subject to achievement of performance conditions for the three year performance period ending on 31 December 2018 and 22,500 share options may vest in May 2020, subject to the achievement of performance conditions for the three year performance period ending on 31 December 2019.

Further details of the performance targets will be set out in the Company's 2016 Annual Report.

c)

Price(s) and volume(s)

Price(s)	Volume(s)
1.   Option Exercise price of GBP 71.81 2.     Nil.	1.   67,500 2.   38,917

d)

Aggregated information

-       Aggregated volume

-       Price

N/A

e)

Date of the transaction

2017-02-27

f)

Place of the transaction

Outside of a trading venue.

For further Information:

Christine Logan

Deputy Company Secretary

Tel +44 (0) 1753 217 800

About RB:

RB* is the world's leading consumer health and hygiene company. The company has operations in over 60 countries, with headquarters in London, Dubai and Amsterdam, and sales in most countries across the globe. The company employs approximately 37,000 people worldwide.

Inspired by a purpose to deliver innovative solutions for healthier lives and happier homes, RB is in the top 20 companies listed on the London Stock Exchange. We are the global No 1 or No 2 in the majority of our fast-growing categories, driven by an exceptional focus on innovation. Our health, hygiene and home portfolio is led by our global Powerbrands including Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Air Wick, Woolite and French's. Our Powerbrands represent 80% of net revenue.

RB is redefining the world of consumer health and hygiene. Our people and unique culture are at the heart of our success. We have a drive for achievement and a passion to outperform wherever we focus, including sustainability where we are targeting a 1/3 reduction in water impact, 1/3 reduction in carbon and 1/3 of net revenue from more sustainable products. We are proud to be Save the Children's largest global partner, with a new vision to radically reduce one of the world's largest killers of under 5s, diarrhoea. 

For more information visit www.rb.com 

*RB is the trading name of the Reckitt Benckiser group of companies

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHBLGDDIUDBGRI